MedTrace Logo

Evaluation of New Custom Made Hearing Product Technology and Shell Modification

NCT02545569 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2019-08-30

No results posted yet for this study

Summary

The purpose of this evaluation is to receive the greatest benefit of new custom made hearing product technology and shell modification for the end customer and to continual improve the custom made hearing products.

Conditions

  • Hearing Loss, Bilateral or Unilateral

Interventions

DEVICE

hearing aid (MD class IIa) - ITE, BTE, RIC

Hearing aid means any wearable instrument or device designed for, offered for the purpose of, or represented as aiding persons with or compensating for, impaired hearing.

Sponsors & Collaborators

  • Phonak AG, Switzerland

    lead INDUSTRY

Principal Investigators

  • Jana-Kosima Schwarzlos, B.Sc. · Switzerland, Sonova AG, CH-8712 Staefa, Zurich

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-06
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02545569 on ClinicalTrials.gov